OTC Markets OTCPK - Delayed Quote USD

Ambu A/S (AMBBY)

Compare
18.37 0.00 (0.00%)
At close: October 15 at 4:00 PM EDT
Loading Chart for AMBBY
DELL
  • Previous Close 18.50
  • Open 18.50
  • Bid 17.67 x 40000
  • Ask 18.91 x 46000
  • Day's Range 18.37 - 18.63
  • 52 Week Range 9.45 - 22.65
  • Volume 1,318
  • Avg. Volume 171
  • Market Cap (intraday) 4.945B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 73.48
  • EPS (TTM) 0.25
  • Earnings Date Nov 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 15, 2021
  • 1y Target Est --

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

www.ambu.com

4,900

Full Time Employees

September 30

Fiscal Year Ends

Recent News: AMBBY

View More

Performance Overview: AMBBY

Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMBBY
20.07%
OMX Copenhagen 25 Index
6.22%

1-Year Return

AMBBY
84.62%
OMX Copenhagen 25 Index
15.01%

3-Year Return

AMBBY
29.69%
OMX Copenhagen 25 Index
1.89%

5-Year Return

AMBBY
54.26%
OMX Copenhagen 25 Index
13.36%

Compare To: AMBBY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMBBY

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    4.99B

  • Enterprise Value

    5.00B

  • Trailing P/E

    74.35

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.35

  • Price/Book (mrq)

    5.82

  • Enterprise Value/Revenue

    6.46

  • Enterprise Value/EBITDA

    35.73

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.55%

  • Return on Assets (ttm)

    5.27%

  • Return on Equity (ttm)

    8.19%

  • Revenue (ttm)

    5.26B

  • Net Income Avi to Common (ttm)

    450M

  • Diluted EPS (ttm)

    0.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    534M

  • Total Debt/Equity (mrq)

    10.64%

  • Levered Free Cash Flow (ttm)

    440.88M

Company Insights: AMBBY

People Also Watch